{"commentary":{"count":79,"free_build_floor":8,"listing_floor":3,"by_channel":{"x_thread":70,"podcast":6,"youtube":3},"note":"Indexed podcasts, YouTube videos and X posts that name this trial. A report screens them, searches for more and cites what clinicians said when it is built."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT02302105\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's public preview; the full report is still bought."},"name":"POP-RT","nct_id":"NCT02302105","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=pop-rt-nct02302105. The price is fixed at order. We build the report after the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1950,"size":"deep","size_rule":"Deep: 41+ commentary sources"},"registry":{"acronym":"POP-RT","arms":[{"description":"66-68 Gray (Gy) in 25 fractions will be prescribed for the prostate PTV","label":"Prostate Only","type":"ACTIVE_COMPARATOR"},{"description":"66-68 Gray (Gy) in 25 fractions will be prescribed for the prostate PTV and 50 Gy in 25 fractions to nodal region .","label":"Whole Pelvis","type":"EXPERIMENTAL"}],"collaborators":[],"completion_date":{"date":"2026-10-23","type":"ESTIMATED"},"conditions":["Prostate Cancer"],"enrollment":{"count":224,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"IGRT","type":"RADIATION"}],"last_update":"2025-02-13","lead_sponsor":"Tata Memorial Centre","official_title":"Prospective Phase III Randomized Trial of Prostate Only or Whole Pelvic RadioTherapy in High Risk Prostate Cancer (POP-RT) Trial","overall_status":"ACTIVE_NOT_RECRUITING","phases":["NA"],"primary_completion_date":{"date":"2017-08-22","type":"ACTUAL"},"primary_outcomes":[{"measure":"Biochemical Disease Free Survival","timeFrame":"5 years"}],"references":[{"citation":"Maitre P, Maheshwari G, Sarkar J, Singh P, Kannan S, Dutta S, Phurailatpam R, Raveendran V, Prakash G, Menon S, Joshi A, Pal M, Arora A, Murthy V. Late Urinary Toxicity and Quality of Life With Pelvic Radiation Therapy for High-Risk Prostate Cancer: Dose-Effect Relations in the POP-RT Randomized Phase 3 Trial. Int J Radiat Oncol Biol Phys. 2024 Oct 1;120(2):537-543. doi: 10.1016/j.ijrobp.2024.03.023. Epub 2024 Mar 28.","pmid":"38552989","type":"RESULT"},{"citation":"Murthy V, Maitre P, Kannan S, Panigrahi G, Krishnatry R, Bakshi G, Prakash G, Pal M, Menon S, Phurailatpam R, Mokal S, Chaurasiya D, Popat P, Sable N, Agarwal A, Rangarajan V, Joshi A, Noronha V, Prabhash K, Mahantshetty U. Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial. J Clin Oncol. 2021 Apr 10;39(11):1234-1242. doi: 10.1200/JCO.20.03282. Epub 2021 Jan 26.","pmid":"33497252","type":"RESULT"},{"citation":"Murthy V, Maitre P, Bhatia J, Kannan S, Krishnatry R, Prakash G, Bakshi G, Pal M, Menon S, Mahantshetty U. Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial. Radiother Oncol. 2020 Apr;145:71-80. doi: 10.1016/j.radonc.2019.12.006. Epub 2020 Jan 7.","pmid":"31923712","type":"RESULT"}],"start_date":{"date":"2011-11-25","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Randomized Trial of Prostate Only or Pelvic RT in High Risk Prostate Cancer","url":"https://clinicaltrials.gov/study/NCT02302105"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"2.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/pop-rt-nct02302105"}